<?xml version="1.0" encoding="UTF-8"?>
<ref id="B73">
 <label>73.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Azevedo</surname>
    <given-names>AS</given-names>
   </name>
   <name>
    <surname>Yamamura</surname>
    <given-names>AM</given-names>
   </name>
   <name>
    <surname>Freire</surname>
    <given-names>MS</given-names>
   </name>
   <name>
    <surname>Trindade</surname>
    <given-names>GF</given-names>
   </name>
   <name>
    <surname>Bonaldo</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Galler</surname>
    <given-names>R</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>DNA vaccines against dengue v√≠rus type 2 based on truncate envelope protein or its domain III</article-title>. 
  <source>PLoS ONE.</source> (
  <year>2011</year>) 
  <volume>6</volume>:
  <fpage>e20528</fpage>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0020528</pub-id>
  <pub-id pub-id-type="pmid">21779317</pub-id>
 </mixed-citation>
</ref>
